述评(Commentary)

肝癌的转化医学研究——从基础到临床

Published at: 2016年第25卷第1期

周俭 1 , 肖永胜 1
1 复旦大学附属中山医院 肝癌研究所,上海 200032
通讯作者 俭 周 Email: zhou.jian@zs-hospital.sh.cn
DOI: 10.3978/j.issn.1005-6947.10.3978/j.issn.1005-6947.2016.01.001
基金:

摘要

肝细胞癌的总体疗效不佳,基础研究与临床实践之间的巨大鸿沟是导致疗效难以进一步提高的瓶颈。转化医学从肝癌的早期诊断、药物筛选、干预新策略的制定、现有治疗方法不足的弥补以及复发转移的早期预测等方面为肝癌实现从基础研究到临床实践的跨越搭建了重要桥梁。


Translational medical research of hepatocellular carcinoma: from bench to bedside

Abstract

The overall efficacy in treatment of hepatocellular carcinoma (HCC) is not satisfactory, and the huge gap between basic science and clinical practice is a major bottleneck for the failure of its further improvement. Translational medicine builds an important bridge to connect between HCC basic research and clinical practice from the respects of early diagnosis, drug screening, new intervention strategy making, and compensation for the shortcomings of the recent treatment methods as well as early prediction of recurrence and metastasis.


comments powered by Disqus

全文

引用

引用本文: 俭 周, 永胜 肖. 肝癌的转化医学研究——从基础到临床[J]. 中国普通外科杂志, 2016, 25(1): 1-5.
Cite this article as: ZHOU Jian, XIAO Yongsheng . Translational medical research of hepatocellular carcinoma: from bench to bedside[J]. Chin J Gen Surg, 2016, 25(1): 1-5.